141 related articles for article (PubMed ID: 15661437)
21. Spinal ERK2 activation through δ2-opioid receptors contributes to nociceptive behavior induced by intrathecal injection of leucine-enkephalin.
Komatsu T; Katsuyama S; Mizoguchi H; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
Peptides; 2014 Apr; 54():131-9. PubMed ID: 24480726
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy.
Nichols ML; Lopez Y; Ossipov MH; Bian D; Porreca F
Pain; 1997 Feb; 69(3):317-322. PubMed ID: 9085307
[TBL] [Abstract][Full Text] [Related]
23. Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons.
Hauser KF; Foldes JK; Turbek CS
Exp Neurol; 1999 Dec; 160(2):361-75. PubMed ID: 10619553
[TBL] [Abstract][Full Text] [Related]
24. Dynorphin A(1-17) mediates midazolam antagonism of morphine antinociception in mice.
Rady JJ; Fujimoto JM
Pharmacol Biochem Behav; 1993 Oct; 46(2):331-9. PubMed ID: 7903457
[TBL] [Abstract][Full Text] [Related]
25. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone.
Vanderah TW; Laughlin T; Lashbrook JM; Nichols ML; Wilcox GL; Ossipov MH; Malan TP; Porreca F
Pain; 1996 Dec; 68(2-3):275-81. PubMed ID: 9121815
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic effects of dynorphins through nonopioid intracellular mechanisms.
Tan-No K; Cebers G; Yakovleva T; Hoon Goh B; Gileva I; Reznikov K; Aguilar-Santelises M; Hauser KF; Terenius L; Bakalkin G
Exp Cell Res; 2001 Sep; 269(1):54-63. PubMed ID: 11525639
[TBL] [Abstract][Full Text] [Related]
27. Antinociceptive effect produced by intracerebroventricularly administered dynorphin A is potentiated by p-hydroxymercuribenzoate or phosphoramidon in the mouse formalin test.
Tan-No K; Ohshima K; Taira A; Inoue M; Niijima F; Nakagawasai O; Tadano T; Nylander I; Silberring J; Terenius L; Kisara K
Brain Res; 2001 Feb; 891(1-2):274-80. PubMed ID: 11164832
[TBL] [Abstract][Full Text] [Related]
28. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats.
Malan TP; Ossipov MH; Gardell LR; Ibrahim M; Bian D; Lai J; Porreca F
Pain; 2000 May; 86(1-2):185-94. PubMed ID: 10779675
[TBL] [Abstract][Full Text] [Related]
29. Radioligand binding studies reveal agmatine is a more selective antagonist for a polyamine-site on the NMDA receptor than arcaine or ifenprodil.
Gibson DA; Harris BR; Rogers DT; Littleton JM
Brain Res; 2002 Oct; 952(1):71-7. PubMed ID: 12363406
[TBL] [Abstract][Full Text] [Related]
30. Direct evidence for the ongoing brain activation by enhanced dynorphinergic system in the spinal cord under inflammatory noxious stimuli.
Taketa Y; Niikura K; Kobayashi Y; Furuya M; Shimizu T; Narita M; Imai S; Kuzumaki N; Maitani Y; Yamazaki M; Inada E; Iseki M; Suzuki T; Narita M
Anesthesiology; 2010 Feb; 112(2):418-31. PubMed ID: 20068450
[TBL] [Abstract][Full Text] [Related]
31. Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2.
Mizoguchi H; Watanabe H; Hayashi T; Sakurada W; Sawai T; Fujimura T; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2006 Apr; 317(1):362-8. PubMed ID: 16394196
[TBL] [Abstract][Full Text] [Related]
32. Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphin antiserum.
Bian D; Ossipov MH; Ibrahim M; Raffa RB; Tallarida RJ; Malan TP; Lai J; Porreca F
Brain Res; 1999 Jun; 831(1-2):55-63. PubMed ID: 10411983
[TBL] [Abstract][Full Text] [Related]
33. Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: pharmacological and genetic evidences.
Rizzi A; Nazzaro C; Marzola GG; Zucchini S; Trapella C; Guerrini R; Zeilhofer HU; Regoli D; Calo' G
Pain; 2006 Sep; 124(1-2):100-8. PubMed ID: 16697109
[TBL] [Abstract][Full Text] [Related]
34. Pre-emptive dynorphin and N-methyl-D-aspartate glutamate receptor antagonism alters spinal immunocytochemistry but not allodynia following complete peripheral nerve injury.
Wagner R; Deleo JA
Neuroscience; 1996 May; 72(2):527-34. PubMed ID: 8737421
[TBL] [Abstract][Full Text] [Related]
35. Delayed postoperative latent pain sensitization revealed by the systemic administration of opioid antagonists in mice.
Campillo A; Cabañero D; Romero A; García-Nogales P; Puig MM
Eur J Pharmacol; 2011 Apr; 657(1-3):89-96. PubMed ID: 21300053
[TBL] [Abstract][Full Text] [Related]
36. Leptin enhances NMDA-induced spinal excitation in rats: A functional link between adipocytokine and neuropathic pain.
Tian Y; Wang S; Ma Y; Lim G; Kim H; Mao J
Pain; 2011 Jun; 152(6):1263-1271. PubMed ID: 21376468
[TBL] [Abstract][Full Text] [Related]
37. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists.
Aanonsen LM; Wilcox GL
J Pharmacol Exp Ther; 1987 Oct; 243(1):9-19. PubMed ID: 2822907
[TBL] [Abstract][Full Text] [Related]
38. Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice.
Gadotti VM; Tibola D; Paszcuk AF; Rodrigues AL; Calixto JB; Santos AR
Brain Res; 2006 Jun; 1093(1):116-22. PubMed ID: 16765330
[TBL] [Abstract][Full Text] [Related]
39. Modulation of NMDA- and (+)TAN-67-induced nociception by GABA(B) receptors in the mouse spinal cord.
Yajima Y; Narita M; Tsuda M; Imai S; Kamei J; Nagase H; Suzuki T
Life Sci; 2000 Dec; 68(6):719-25. PubMed ID: 11205886
[TBL] [Abstract][Full Text] [Related]
40. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
